A Monthly 5-Day Fasting-Mimicking Diet Nearly Doubled Remission Rates in Crohn's Disease: What the Research Shows

A Monthly 5-Day Fasting-Mimicking Diet Nearly Doubled Remission Rates in Crohn's Disease: What the Research Shows

Medical disclaimer: This article summarises published research for informational purposes only. It is not medical advice and is not a substitute for guidance from a qualified health professional. Always consult your doctor before starting any fasting protocol, especially if you have an existing health condition or take medication.

Study at a Glance

What This Study Looked At

Crohn's disease is a chronic inflammatory bowel condition with no cure, and many existing treatments carry real side effects or lose effectiveness over time. This trial asked whether a fasting-mimicking diet (FMD) — a low-calorie, plant-based diet designed to trigger many of the same cellular effects as true fasting while still providing some food — could reduce disease activity in people with mild-to-moderate Crohn's disease. For background on how fasting interacts with the gut more broadly, see Fasting and Digestive Disorders: The Case for Giving Your Gut a Rest and How Fasting Heals the Gut: Rest, Repair, and Renewal.

Who Was Studied

Participant profile: Adults with a confirmed diagnosis of mild-to-moderate Crohn's disease, recruited and treated at Stanford University School of Medicine.

How the fasting-mimicking diet worked in this study: Participants in the FMD arm ate a pre-packaged, low-calorie, plant-based diet (roughly 700–1,100 calories per day) for 5 consecutive days out of each month, then returned to their normal baseline diet for the remaining days of the month. This cycle repeated for 3 consecutive months. The FMD products used in the trial were supplied by L-Nutra, the company co-founded by fasting researcher Valter Longo, a senior author on the study.

What the Researchers Found

Clinical response and remission

• The primary outcome — clinical response, defined as at least a 70-point reduction in the Crohn's Disease Activity Index (CDAI) — was met by 69.2% of the FMD group compared with 43.8% of controls.
• Nearly two-thirds of patients on the fasting-mimicking diet reached clinical remission, compared with just over a third of the control group.
• Markers of intestinal inflammation were also reported as reduced in the FMD group, consistent with the clinical improvements.

What Did Not Change

• Full details on lean mass or muscle changes were not highlighted in the available coverage of this trial — it was designed and reported primarily as a disease-activity study, not a body composition study.
• Exact p-values and confidence intervals for the primary and secondary outcomes were not available in the secondary sources reviewed; readers wanting the precise statistics should consult the full Nature Medicine paper directly.

What the Researchers Concluded

The Stanford research team concluded that a monthly, time-limited fasting-mimicking diet produced meaningfully higher rates of clinical response and remission than a standard diet in patients with mild-to-moderate Crohn's disease, positioning FMD as a promising, food-based adjunct to existing Crohn's management.

What This Means If You Fast

• This is one of the strongest human RCTs to date linking a fasting-based intervention directly to inflammatory bowel disease remission, rather than just general inflammation markers — see Does Intermittent Fasting Reduce Inflammation? for the broader mechanism.
• The protocol was structured and time-limited, not open-ended. Participants ate a specific low-calorie plant-based diet for 5 days a month, not a daily fasting routine — this is a meaningfully different approach from typical 16:8 time-restricted eating.
• Patients in this trial continued to eat every month — this was not prolonged fasting or starvation. The FMD still provided 700–1,100 calories per day during the 5-day stretches.
• This should not be attempted without medical supervision if you have Crohn's disease or another IBD diagnosis — the trial was conducted under clinical monitoring with a specific, tested product, not a self-designed diet.
• For general gut health interest without an IBD diagnosis, see Can Intermittent Fasting Improve Gut Health? for how more common fasting patterns affect digestive health.

Study Limitations

• Open-label design — neither patients nor researchers were blinded to group assignment, which can inflate perceived benefit through expectation effects.
• Relatively small sample size (97 total, split across two unevenly sized arms), typical for a single-center IBD trial but limiting how confidently results generalize.
• A financial conflict of interest is present: senior author Valter Longo holds equity in L-Nutra, the company supplying the fasting-mimicking diet products used in the trial, and holds related patents.
• Only mild-to-moderate Crohn's disease was studied — these findings should not be extended to severe or complicated Crohn's disease without further research.
• Exact statistical significance values (p-values, confidence intervals) were not available in the secondary sources used to compile this summary, since direct access to the full paper was blocked at generation time.
• Longer-term durability of remission beyond the 3-month intervention period was not covered in the sources reviewed.

Source

Kulkarni, C., Fardeen, T., Gubatan, J., et al. (2026). A fasting-mimicking diet in patients with mild-to-moderate Crohn's disease: a randomized controlled trial. Nature Medicine, 32, 1023–1033. PMID: 41530382

Frequently Asked Questions

Does fasting help with Crohn's disease?

This 2026 Stanford randomized trial found that a monthly 5-day fasting-mimicking diet, repeated for 3 months, led to clinical remission in 64.6% of Crohn's disease patients compared to 37.5% on a standard diet.

What is a fasting-mimicking diet?

It's a low-calorie (roughly 700–1,100 calories/day), plant-based eating plan designed to trigger many of the metabolic effects of true fasting — like reduced inflammation — while still providing some nutrition, unlike a complete water fast.

How often did participants follow the fasting-mimicking diet?

Five consecutive days per month, for three consecutive months, returning to their normal diet on all other days.

Is this the same as intermittent fasting or time-restricted eating?

Not exactly. Intermittent fasting and time-restricted eating typically involve daily fasting windows (like 16:8). This study used a monthly multi-day, low-calorie protocol — a different structure with its own specific evidence base.

Should I try this if I have Crohn's disease?

Only under medical supervision. This trial used a specific, tested commercial product and clinical monitoring — it is not a recommendation to self-design a similar diet without a doctor's involvement, especially given the underlying disease being treated.

Related Research and Articles

• Fasting and Digestive Disorders: The Case for Giving Your Gut a Rest
• How Fasting Heals the Gut: Rest, Repair, and Renewal
• Can Intermittent Fasting Improve Gut Health?
• Does Intermittent Fasting Reduce Inflammation?
• Intermittent Fasting and Inflammation: The Research Explained
• Can Intermittent Fasting Help with IBS or Digestive Issues?
• Why Fermentation in the Gut Causes Disease (and How Fasting Stops It)

Want the complete guide to fasting? Get Intermittent Fasting in Practice on Amazon — and claim 3 months free on our fasting app at fastinginpractice.com/redeem.